A Validated Tool Can Predict Risk or Nonrisk of Graves’ Orbitopathy During Antithyroid Drug Treatment of Hyperthyroid Graves’ Disease

Clinical Thyroidology, Volume 30, Issue 6, Page 246-250, June 2018.


https://ift.tt/2loac6p